These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36727221)

  • 1. A promising subgroup identification method based on a genetic algorithm for censored survival data.
    Zhao L; Zhang W; Wu Y; Cao L; Wang L; Li K
    J Biopharm Stat; 2024 Jan; 34(1):55-77. PubMed ID: 36727221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subgroup identification for treatment selection in biomarker adaptive design.
    Lu TP; Chen JJ
    BMC Med Res Methodol; 2015 Dec; 15():105. PubMed ID: 26646831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data.
    Zhang P; Ma J; Chen X; Shentu Y
    Stat Med; 2020 Dec; 39(28):4133-4146. PubMed ID: 32786155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.
    Huber C; Benda N; Friede T
    Pharm Stat; 2019 Oct; 18(5):600-626. PubMed ID: 31270933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.
    Lipkovich I; Dmitrienko A; Denne J; Enas G
    Stat Med; 2011 Sep; 30(21):2601-21. PubMed ID: 21786278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplicity issues in exploratory subgroup analysis.
    Lipkovich I; Dmitrienko A; Muysers C; Ratitch B
    J Biopharm Stat; 2018; 28(1):63-81. PubMed ID: 29173045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy.
    Chen X; Zhang J; Jiang L; Yan F
    BMC Med Res Methodol; 2023 Mar; 23(1):66. PubMed ID: 36941537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES.
    Lipkovich I; Dmitrienko A
    J Biopharm Stat; 2014; 24(1):130-53. PubMed ID: 24392982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAPITAL: Optimal subgroup identification via constrained policy tree search.
    Cai H; Lu W; Marceau West R; Mehrotra DV; Huang L
    Stat Med; 2022 Sep; 41(21):4227-4244. PubMed ID: 35799329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials.
    Schnell PM; Müller P; Tang Q; Carlin BP
    Clin Trials; 2018 Feb; 15(1):75-86. PubMed ID: 29035083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depth importance in precision medicine (DIPM): a tree- and forest-based method for right-censored survival outcomes.
    Chen V; Zhang H
    Biostatistics; 2022 Jan; 23(1):157-172. PubMed ID: 32424406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroup analysis in the heterogeneous Cox model.
    Hu X; Huang J; Liu L; Sun D; Zhao X
    Stat Med; 2021 Feb; 40(3):739-757. PubMed ID: 33169428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials.
    Lipkovich I; Dmitrienko A; B R
    Stat Med; 2017 Jan; 36(1):136-196. PubMed ID: 27488683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials.
    Zhang Z; Chen R; Soon G; Zhang H
    Stat Med; 2018 Jan; 37(1):1-11. PubMed ID: 28948633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of predictive signatures for treatment selection in precision medicine with survival outcomes.
    Chen YC; Lee UJ; Tsai CA; Chen JJ
    Pharm Stat; 2018 Mar; 17(2):105-116. PubMed ID: 29297979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian approach to subgroup identification.
    Berger JO; Wang X; Shen L
    J Biopharm Stat; 2014; 24(1):110-29. PubMed ID: 24392981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Q-Finder: An Algorithm for Credible Subgroup Discovery in Clinical Data Analysis - An Application to the International Diabetes Management Practice Study.
    Esnault C; Gadonna ML; Queyrel M; Templier A; Zucker JD
    Front Artif Intell; 2020; 3():559927. PubMed ID: 33733209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Stability in Subgroup Identification for Stratified Medicine.
    Hair GM; Jemielita T; Mt-Isa S; Schnell PM; Baumgartner R
    Pharm Stat; 2024; 23(6):945-958. PubMed ID: 38924620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial.
    Altstein LL; Li G; Elashoff RM
    Stat Med; 2011 Mar; 30(7):709-17. PubMed ID: 21394747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.